Structural insights into the transcription-independent apoptotic pathway of p53

키워드

참고문헌 (55)

1. Harris, S. L., "The p53 pathway: positive and negative feedback loops", Oncogene, 24, pp.2899~2908 (2005)
2. Sherr, C. J., "Principles of tumor suppression", Cell, 116, pp.235~246 (2004)
3. Vogelstein, B., "Surfing the p53 network", Nature, 408, pp.307~310 (2000)
4. Vousden, K. H., "Live or let die: the cell's response to p53", Nature Rev, 2, pp.594~604 (2002)
5. Hollstein, M., "p53 mutations in human cancers", Science, 253, pp.49~53 (1991)
6. Ventura, A., "Restoration of p53 function leads to tumour regression in vivo", Nature, 445, pp.661~665 (2007)
7. Xue, W., "Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas", Nature, 445, pp.656~660 (2007)
8. Martins, C. P., "Modeling the therapeutic efficacy of p53 restoration in tumors", Cell, 127, pp.1323~1334 (2006)
9. Kussie, P. H., "Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain", Science, 274, pp.948~953 (1996)
10. Chipuk, J. E., "PUMA couples the nuclear and cytoplasmic proapoptotic function of p53", Science, 309, pp.1732~1735 (2005)
11. Chipuk, J. E., "Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis", Science, 303, pp.1010~1014 (2004)
12. Jiang, P., "The Bad guy cooperates with good cop p53: Bad is transcriptionally up-regulated by p53 and forms a Bad", p53 complex at the mitochondria to induce apoptosis, 2006, pp.26, 9071~9082
13. Leu, J. I., "Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex", Nat. Cell Biol, 6, pp.443~450 (2004)
14. Mihara, M., "p53 has a direct apoptogenic role at the mitochondria", Mol. Cell, 11, pp.577~590 (2003)
15. Tomita, Y., "WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization", J. Biol. Chem, 281, pp.8600~8606 (2006)
16. Zhu, J., "Identification of a novel p53 functional domain that is necessary for mediating apoptosis", J. Biol. Chem, 273, pp.13030~13036 (1998)
17. Chang, J., "Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein", J. Biol. Chem, 270, pp.25014~25019 (1995)
18. Gu, W., "Synergistic activation of transcription by CBP and p53", Nature, 387, pp.819~823 (1997)
19. Uesugi, M., "The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2", Proc. Natl. Aca. Sci. U.S.A, 96, pp.14801~14806 (1999)
20. Ha, J. H., "Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways", J. Biol. Chem, 288, pp.7387~7398 (2013)
21. Ha, J. H., "Molecular mimicry-based repositioning of nutlin-3 to anti-apoptotic Bcl-2 family proteins", J. Am. Chem. Soc, 133, pp.1244~1247 (2011)
22. Bullock, A. N., "Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy", Oncogene, 19, pp.1245~1256 (2000)
23. Hey-Ryun Kim, "FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells", BMB Reports, 45(5), pp.287~292 (2012), 생화학분자생물학회
24. Bing Qin, "MicroRNA let-7c inhibits Bcl-xl expression and regulates ox-LDL-induced endothelial apoptosis", BMB Reports, 45(8), pp.464~469 (2012), 생화학분자생물학회
25. Kelekar, A, "Bcl-2-family proteins: the role of the BH3 domain in apoptosis", Trends Cell Biol, 8, pp.324~330 (1998)
26. Youle, R. J., "The BCL-2 protein family: opposing activities that mediate cell death", Nat. Rev. Mol. Cell Biol, 9, pp.47~59 (2008)
27. Lee, D. H., "Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy", Biochem. Biophys. Res. Commun, 408, pp.541~547 (2011)
28. Sot, B., "Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL", J. Biol. Chem, 282, pp.29193~29200 (2007)
29. Hagn, F., "BclxL changes conformation upon binding to wild-type but not mutant p53 DNA binding domain", J. Biol. Chem, 285, pp.3439~3450 (2010)
30. Petros, A. M., "Defining the p53 DNA-binding domain", Bcl-x(L)-binding interface using NMR, 2004, pp.559, 171~174
31. Dong-Hwa Lee, "A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins", Molecules and Cells, 37(3), pp.264~269 (2014), 한국분자세포생물학회[DOI]
32. Chipuk, J. E., "Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription", Cancer Cell, 4, pp.371~381 (2003)
33. Sayan, B. S., "p53 is cleaved by caspases generating fragments localizing to mitochondria", J. Biol. Chem, 281, pp.13566~13573 (2006)
34. Xu, H., "The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl", Biochem. Biophys. Res. Commun, 341, pp.938~944 (2006)
35. Xu, H., "The MDM2-binding region in the transactivation domain of p53 also acts as a Bcl-X(L)-binding motif", Biochemistry, 48, pp.12159~12168 (2009)
36. Bharatham, N., "Molecular basis of Bcl-X(L)-p53 interaction: insights from molecular dynamics simulations", PLoS One, 6, pp.e26014~ (2011)
37. Ha, J., "Molecular Interaction between a Bcl-2 Homolog from Kaposi Sarcoma Virus and p53", Bull. Korean Chem. Soc, 30, pp.1655~ (2009)
38. Lee, M. S, "Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apopinsights into the transcription-independent apoptotic pathway of p53 Seung-Wook Chi 172 BMB Reports http:", Biochem. Biophys. Res. Commun, pp.2014, 445[DOI]
39. Shin, J. S., "Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy", Biochem. Biophys. Res. Commun, 443, pp.882~887 (2014)
40. Fesik, S. W., "Promoting apoptosis as a strategy for cancer drug discovery", Nat. Rev. Cancer, 5, pp.876~885 (2005)
41. Vassilev, L. T., "In vivo activation of the p53 pathway by small-molecule antagonists of MDM2", Science, 303, pp.844~848 (2004)
42. Kojima, K., "Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription- dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia", Blood, 108, pp.993~1000 (2006)
43. Vaseva, A. V., "The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells", Cell Cycle, 8, pp.1711~1719 (2009)
44. Saha, M. N., "Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways", Cancer Biol. Ther, 10, pp.567~578 (2010)
45. Kang, M. H, "Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy", Clin. Cancer Res, 15, pp.1126~1132 (2009)
46. Lessene, G., "BCL-2 family antagonists for cancer therapy", Nat. Rev. Drug Discov, 7, pp.989~1000 (2008)
47. Oltersdorf, T, "An inhibitor of Bcl-2 family proteins induces regression of solid tumours", Nature, 435, pp.677~681 (2005)
48. Konopleva, M., "Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia", Cancer Cell, 10, pp.375~388 (2006)
49. van Delft, M. F., "The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak", Bax if Mcl-1 is neutralized, 2006, pp.10, 389~399
50. Shin, J. S., "Structural insights into the dual-targeting mechanism of Nutlin-3. Biochem", Biophys. Res. Commun, 420, pp.48~53 (2012)
51. Lee, E. F., "High-resolution structural characterization of a helical alpha", beta-peptide foldamer bound to the anti-apoptotic protein Bcl-xL, 2009, pp.48, 4318~4322
52. Vassilev, L. T., "MDM2 inhibitors for cancer therapy", Trends Mol. Med, 13, pp.23~31 (2007)
53. Kojima, K., "Concomitant inhibition of MDM2 and Bcl-2 protein function synergistically induce mitochondrial apoptosis in AML", Cell Cycle, 5, pp.2778~2786 (2006)
54. Wade, M., "BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death", Cell Cycle, 7, pp.1973~1982 (2008)
55. Porter, J. R., "Profiling small molecule inhibitors against helix-receptor interactions: the Bcl-2 family inhibitor BH3I-1 potently inhibits p53", hDM2, 2010, pp.46, 8020~8022

관련 논문AI추천